Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19Monique G.P. van der Wijst, Chun Ye, Tianna Grant et al.|Science Translational Medicine|2021Cited by 237
Spatially resolved, multimodal in vivo Perturb-seq using antibody-based cell hashingAlexander A. Nevue, David Lara‐Astiaso, George C. Hartoularos et al.|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0